Unichem Labs irregular heartbeat drug Amiodarone gets USFDA approval
Mumbai: Unichem Laboratories Limited has received ANDA approval for its Amiodarone Tablets, USP, 200 mg from the United States Food and Drug Administration (USFDA) to market a generic version of CORDARONE® (amiodarone) tablets of Wyeth Pharmaceuticals Inc.
Amiodarone tablets are indicated for the treatment of documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated.
The product will be commercialized from Unichem's Ghaziabad Plant.
Read also: Unichem Labs gets USFDA nod to Baclofen Tablets for spasticity relief
Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.
Read also: Unichem Labs gets USFDA nod to Cyclobenzaprine Hydrochloride Tablets to treat muscle spasm
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.